agilon health (NYSE:AGL) Earns "Market Perform" Rating from JMP Securities

agilon health (NYSE:AGL - Get Free Report)'s stock had its "market perform" rating reissued by analysts at JMP Securities in a research report issued to clients and investors on Monday,Benzinga reports.

Several other analysts have also issued reports on AGL. Cowen reissued a "hold" rating on shares of agilon health in a report on Tuesday, April 15th. Sanford C. Bernstein raised shares of agilon health from a "market perform" rating to an "outperform" rating and increased their target price for the stock from $3.30 to $8.50 in a report on Tuesday, April 8th. Needham & Company LLC restated a "hold" rating on shares of agilon health in a research note on Friday, March 21st. Robert W. Baird dropped their price target on shares of agilon health from $6.00 to $5.00 and set a "neutral" rating for the company in a research report on Tuesday, April 15th. Finally, Citigroup upgraded shares of agilon health from a "neutral" rating to a "buy" rating and raised their price objective for the company from $3.25 to $5.00 in a research report on Friday, April 25th. Two equities research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and four have given a buy rating to the stock. According to MarketBeat, the company has an average rating of "Hold" and an average target price of $4.81.

agilon health Stock Performance

Shares of AGL stock traded up $0.23 during trading hours on Monday, reaching $4.16. The company had a trading volume of 4,728,140 shares, compared to its average volume of 4,858,557. The firm has a market cap of $1.72 billion, a PE ratio of -4.43 and a beta of 0.38. The business has a fifty day moving average price of $4.23 and a 200-day moving average price of $3.17. agilon health has a one year low of $1.50 and a one year high of $7.73. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29.

Institutional Trading of agilon health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. JPMorgan Chase & Co. increased its stake in agilon health by 326.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company's stock worth $5,563,000 after buying an additional 1,083,492 shares during the period. Inspire Investing LLC raised its stake in shares of agilon health by 106.6% in the fourth quarter. Inspire Investing LLC now owns 217,550 shares of the company's stock valued at $413,000 after acquiring an additional 112,241 shares in the last quarter. Cerity Partners LLC purchased a new position in agilon health in the fourth quarter valued at $34,000. Geode Capital Management LLC boosted its stake in shares of agilon health by 0.5% in the 4th quarter. Geode Capital Management LLC now owns 6,928,724 shares of the company's stock valued at $13,168,000 after buying an additional 35,207 shares during the period. Finally, KLP Kapitalforvaltning AS acquired a new position in shares of agilon health during the fourth quarter worth about $111,000.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.